FR106F - - Google Patents

Info

Publication number
FR106F
FR106F FR106DF FR106F FR 106 F FR106 F FR 106F FR 106D F FR106D F FR 106DF FR 106 F FR106 F FR 106F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of FR106F publication Critical patent/FR106F/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
FR106D 1964-12-21 Active FR106F (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR999352 1964-12-21

Publications (1)

Publication Number Publication Date
FR106F true FR106F (es)

Family

ID=8845212

Family Applications (2)

Application Number Title Priority Date Filing Date
FR106D Active FR106F (es) 1964-12-21
FR873265D Active FR1625M (fr) 1964-12-21 1961-09-15 Médicament a action nutritive et antitoxique.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR873265D Active FR1625M (fr) 1964-12-21 1961-09-15 Médicament a action nutritive et antitoxique.

Country Status (1)

Country Link
FR (2) FR1625M (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568124A1 (fr) * 1984-07-24 1986-01-31 Cortial Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
EP0342139A2 (fr) * 1988-05-09 1989-11-15 Cortial S.A. Utilisation de l'Aspartate d'Arginine pour la fabrication d'un médicament pour traiter certains troubles de la mémoire
WO2021089875A1 (en) 2019-11-07 2021-05-14 Cytoki Pharma Aps Therapeutic derivatives of interleukin-22
WO2022238503A1 (en) 2021-05-11 2022-11-17 Cytoki Pharma Aps Therapeutic derivatives of interleukin-22

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108689887A (zh) * 2018-04-23 2018-10-23 宜兴市前成生物有限公司 一种工业化生产l-精氨酸-l-天门冬氨酸的方法

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568124A1 (fr) * 1984-07-24 1986-01-31 Cortial Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
EP0342139A2 (fr) * 1988-05-09 1989-11-15 Cortial S.A. Utilisation de l'Aspartate d'Arginine pour la fabrication d'un médicament pour traiter certains troubles de la mémoire
EP0342139A3 (en) * 1988-05-09 1990-09-19 Societe Cortial S.A. Medicine containing arginine aspartate for treating inflictions of the memory
WO2021089875A1 (en) 2019-11-07 2021-05-14 Cytoki Pharma Aps Therapeutic derivatives of interleukin-22
WO2022238503A1 (en) 2021-05-11 2022-11-17 Cytoki Pharma Aps Therapeutic derivatives of interleukin-22
WO2022238510A1 (en) 2021-05-11 2022-11-17 Cytoki Pharma Aps Therapeutic derivatives of interleukin-22

Also Published As

Publication number Publication date
FR1625M (fr) 1962-12-26

Similar Documents

Publication Publication Date Title
FR106F (es)
BE646455A (es)
BE642400A (es)
BE629793A (es)
BE628611A (es)
BE627931A (es)
BE623398A (es)
BE627390A (es)
BE627057A (es)
BE626083A (es)
BE626684A (es)
BE636791A (es)
BE622126A (es)
BE621510A (es)
BE613833A (es)
BE661147A (es)
BE660823A (es)
BE660669A (es)
BE659865A (es)
BE659675A (es)
BE658573A (es)
BE658275A (es)
BE658153A (es)
BE647813A (es)
BE647501A (es)